Prognostic Factors in Breast Cancer
Author Information
Author(s): W.R. Miller
Primary Institution: ICRF Medical Oncology Unit, Western General Hospital
Conclusion
The editorial discusses the need for better prognostic factors in breast cancer and highlights the limitations of current methods like S-phase analysis.
Supporting Evidence
- The editorial emphasizes the need for prognostic factors due to the heterogeneity of breast cancer.
- Current widely used factors are mainly related to clinical staging, particularly lymph node involvement.
- High tumour proliferation is generally associated with poor prognosis in breast cancer.
Takeaway
Doctors need better ways to predict how breast cancer will behave so they can give the right treatment to each patient.
Methodology
The editorial reviews the literature on prognostic factors in breast cancer, particularly focusing on S-phase analysis and nuclear ploidy.
Potential Biases
There are risks of selection bias due to the exclusion of patients and variability in treatment across different hospitals.
Limitations
The study's findings are largely negative and may not reflect the true potential of S-phase analysis due to methodological issues.
Participant Demographics
Patients were treated in a standardized manner across a small number of hospitals.
Want to read the original?
Access the complete publication on the publisher's website